Our Commitment

The field of psychedelic therapy has garnered increasing attention in recent years, with numerous studies highlighting its potential benefits for mental health treatment. Research indicates that psychedelics, such as psilocybin and MDMA, can significantly reduce symptoms of depression, anxiety, and PTSD in controlled therapeutic settings. 

As the understanding of psychedelics evolves, it is imperative to promote education and awareness surrounding their therapeutic applications. These conversations play a crucial role in demystifying psychedelics and addressing the stigma that has historically surrounded their use.

In alignment with our commitment to advancing these conversations, we allocate 10% of our profits to non-profit organizations dedicated to supporting educational initiatives that can help cultivate a more informed public discourse on the benefits and risks associated with psychedelics. This includes workshops, seminars, and community outreach programs that aim to educate both professionals and the general public about the science behind psychedelics and their therapeutic potential. By fostering a well-informed community, we can contribute to a more nuanced understanding of these substances and their role in health care.

In conclusion, the advancement of education in psychedelics is a critical component of promoting their therapeutic use. By committing to donate a portion of profits to non-profit organizations focused on education, we are taking a proactive step towards supporting this burgeoning field. As more evidence emerges regarding the benefits of psychedelic therapy, it is essential to continue fostering education and awareness to ensure that these treatments are accessible and understood within the broader context of all health care.